Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 7 studies | 47% ± 19% | |
hepatocyte | 6 studies | 78% ± 27% | |
endothelial cell | 4 studies | 60% ± 28% | |
endothelial cell of sinusoid | 4 studies | 45% ± 19% | |
hepatic stellate cell | 3 studies | 65% ± 28% | |
macrophage | 3 studies | 51% ± 26% | |
epithelial cell | 3 studies | 34% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 4 studies | 67% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 237550.38 | 226 / 226 | 91% | 10181.03 | 369 / 406 |
kidney | 90% | 101.20 | 80 / 89 | 0% | 12.42 | 3 / 901 |
pancreas | 70% | 20.21 | 229 / 328 | 1% | 0.95 | 1 / 178 |
spleen | 69% | 182.62 | 167 / 241 | 0% | 0 | 0 / 0 |
stomach | 62% | 16.31 | 224 / 359 | 1% | 2.07 | 3 / 286 |
lung | 59% | 22.26 | 342 / 578 | 0% | 3.61 | 5 / 1155 |
intestine | 59% | 3328.14 | 568 / 966 | 0% | 10.56 | 2 / 527 |
peripheral blood | 58% | 578.28 | 535 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 55% | 17.14 | 143 / 258 | 0% | 0 | 0 / 230 |
ovary | 52% | 13.96 | 93 / 180 | 0% | 0 | 0 / 430 |
uterus | 50% | 17.59 | 85 / 170 | 0% | 0.84 | 2 / 459 |
prostate | 50% | 10.30 | 123 / 245 | 0% | 0 | 0 / 502 |
esophagus | 48% | 18.75 | 694 / 1445 | 1% | 1.76 | 1 / 183 |
breast | 47% | 41.75 | 215 / 459 | 0% | 1.58 | 1 / 1118 |
thymus | 47% | 14.24 | 305 / 653 | 0% | 0 | 0 / 605 |
adipose | 45% | 36.91 | 543 / 1204 | 0% | 0 | 0 / 0 |
heart | 41% | 13.64 | 351 / 861 | 0% | 0 | 0 / 0 |
skin | 40% | 15.52 | 720 / 1809 | 0% | 0.90 | 1 / 472 |
blood vessel | 38% | 15.06 | 503 / 1335 | 0% | 0 | 0 / 0 |
brain | 30% | 6.54 | 794 / 2642 | 0% | 0 | 0 / 705 |
muscle | 28% | 5.86 | 222 / 803 | 0% | 0 | 0 / 0 |
bladder | 19% | 1.76 | 4 / 21 | 0% | 0.50 | 1 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045833 | Biological process | negative regulation of lipid metabolic process |
GO_0010903 | Biological process | negative regulation of very-low-density lipoprotein particle remodeling |
GO_0070328 | Biological process | triglyceride homeostasis |
GO_0060621 | Biological process | negative regulation of cholesterol import |
GO_0034382 | Biological process | chylomicron remnant clearance |
GO_0010897 | Biological process | negative regulation of triglyceride catabolic process |
GO_0010916 | Biological process | negative regulation of very-low-density lipoprotein particle clearance |
GO_0010989 | Biological process | negative regulation of low-density lipoprotein particle clearance |
GO_0043691 | Biological process | reverse cholesterol transport |
GO_0032489 | Biological process | regulation of Cdc42 protein signal transduction |
GO_0034379 | Biological process | very-low-density lipoprotein particle assembly |
GO_0010987 | Biological process | negative regulation of high-density lipoprotein particle clearance |
GO_0033700 | Biological process | phospholipid efflux |
GO_0034375 | Biological process | high-density lipoprotein particle remodeling |
GO_0042157 | Biological process | lipoprotein metabolic process |
GO_0019433 | Biological process | triglyceride catabolic process |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0006641 | Biological process | triglyceride metabolic process |
GO_0045717 | Biological process | negative regulation of fatty acid biosynthetic process |
GO_0050995 | Biological process | negative regulation of lipid catabolic process |
GO_0048261 | Biological process | negative regulation of receptor-mediated endocytosis |
GO_0033344 | Biological process | cholesterol efflux |
GO_0051005 | Biological process | negative regulation of lipoprotein lipase activity |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0042627 | Cellular component | chylomicron |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0034366 | Cellular component | spherical high-density lipoprotein particle |
GO_0005769 | Cellular component | early endosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0034361 | Cellular component | very-low-density lipoprotein particle |
GO_0034363 | Cellular component | intermediate-density lipoprotein particle |
GO_0070653 | Molecular function | high-density lipoprotein particle receptor binding |
GO_0015485 | Molecular function | cholesterol binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0055102 | Molecular function | lipase inhibitor activity |
GO_0030234 | Molecular function | enzyme regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | APOC3 |
Protein name | Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3) Apolipoprotein C-III (Apolipoprotein C3) |
Synonyms | hCG_41334 |
Description | FUNCTION: Component of triglyceride-rich very low density lipoproteins (VLDL) and high density lipoproteins (HDL) in plasma . Plays a multifaceted role in triglyceride homeostasis . Intracellularly, promotes hepatic very low density lipoprotein 1 (VLDL1) assembly and secretion; extracellularly, attenuates hydrolysis and clearance of triglyceride-rich lipoproteins (TRLs) . Impairs the lipolysis of TRLs by inhibiting lipoprotein lipase and the hepatic uptake of TRLs by remnant receptors . Formed of several curved helices connected via semiflexible hinges, so that it can wrap tightly around the curved micelle surface and easily adapt to the different diameters of its natural binding partners . . |
Accessions | P02656 A3KPE2 ENST00000630701.1 C9J2Q0 ENST00000375345.3 ENST00000433777.5 ENST00000227667.8 B0YIW2 |